<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36321943</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis.</ArticleTitle><Pagination><StartPage>1953</StartPage><EndPage>1961</EndPage><MedlinePgn>1953-1961</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51688</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on the healthcare system, economy, and society. Studies have reported that COVID-19 may cause various neurologic symptoms, including cognitive impairment. We aimed to assess the causal effect of COVID-19 on neurodegenerative diseases using two-sample Mendelian randomization (MR) study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Genetic variants were obtained from genome-wide association studies (GWAS) summary-level data and meta-analyses. We used the inverse variance-weighted (IVW) method as the primary analysis to estimate causal effects. Sensitivity analyses were performed to make the conclusions more robust and reliable.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that the COVID-19 infection phenotype was associated with a higher risk of AD and inverse associated with the risk of ALS and MS. The hospitalized COVID-19 phenotype was associated with the risk of AD and wasn't associated with ALS and MS. We also found that the severe COVID-19 (main analysis) phenotype was associated with the AD outcome from UK biobank datasets but was not associated with other outcomes. The severe COVID-19 infection phenotype, the severe COVID-19 (subtype analysis) phenotype and the hospitalization risk of COVID-19 were not associated with each outcome.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This MR study suggests a potential association between genetically predicted COVID-19 and a higher risk of AD and a reduced risk of ALS and MS. Further elucidations of this association and underlying mechanisms may inform public health messages to prevent COVID-19 and AD.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Hanyu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7324-0943</Identifier><AffiliationInfo><Affiliation>Department of General Practice, Clinical Medical College &amp; Affiliated Hospital of Chengdu University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Zengyuan</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7216-3165</Identifier><AffiliationInfo><Affiliation>Department of Nutrition, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_17228</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_QA137853</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>10</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36321943</ArticleId><ArticleId IdType="pmc">PMC9735364</ArticleId><ArticleId IdType="doi">10.1002/acn3.51688</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li H, Liu S&#x2010;M, Yu X&#x2010;H, Tang S&#x2010;L, Tang C&#x2010;K. Coronavirus disease 2019 (COVID&#x2010;19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7139247</ArticleId><ArticleId IdType="pubmed">32234466</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Driscoll M, Ribeiro Dos Santos G, Wang L, et&#xa0;al. Age&#x2010;specific mortality and immunity patterns of SARS&#x2010;CoV&#x2010;2. Nature. 2021;590(7844):140&#x2010;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137809</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, et&#xa0;al. The emerging spectrum of COVID&#x2010;19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104&#x2010;3120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro&#x2010;Almagro F, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 is associated with changes in brain structure in UK biobank. Nature. 2022;604(7907):697&#x2010;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et&#xa0;al. Neuropathology of patients with COVID&#x2010;19 in Germany: a post&#x2010;mortem case series. Lancet Neurol. 2020;19(11):919&#x2010;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, et&#xa0;al. Neuroinvasion of SARS&#x2010;CoV&#x2010;2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, Cabral HJ, Hess CP, et&#xa0;al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain. 2009;132(Pt 8):2048&#x2010;2057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714061</ArticleId><ArticleId IdType="pubmed">19460794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry. 2003;64(Suppl):9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12934968</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B, Haure&#x2010;Mirande J&#x2010;V, Funk CC, et&#xa0;al. Multiscale analysis of independent Alzheimer's cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99(1):64&#x2010;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551233</ArticleId><ArticleId IdType="pubmed">29937276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184&#x2010;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et&#xa0;al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et&#xa0;al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2010;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al&#x2010;Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2010;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pender N, Pinto&#x2010;Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33(5):649&#x2010;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">32833751</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Gallo C, Sarnelli MF, et&#xa0;al. Accelerated early progression of amyotrophic lateral sclerosis over the COVID&#x2010;19 pandemic. Brain Sci. 2021;11(10):1291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8534200</ArticleId><ArticleId IdType="pubmed">34679356</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Bedlack R. COVID&#x2010;19&#x2010;accelerated disease progression in two patients with amyotrophic lateral sclerosis. Muscle Nerve. 2021;64(3):E13&#x2010;e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441768</ArticleId><ArticleId IdType="pubmed">34131925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassmann H. Multiple sclerosis pathology and its reflection by imaging technologies: introduction. Brain Pathol. 2018;28(5):721&#x2010;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8028543</ArticleId><ArticleId IdType="pubmed">30375112</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple sclerosis. Nat Rev Dis Primers 2018;4(1):44.</Citation><ArticleIdList><ArticleId IdType="pubmed">30410088</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallantyre EC, Vickaryous N, Anderson V, et&#xa0;al. COVID&#x2010;19 vaccine response in people with multiple sclerosis. Ann Neurol. 2022;91(1):89&#x2010;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652739</ArticleId><ArticleId IdType="pubmed">34687063</ArticleId></ArticleIdList></Reference><Reference><Citation>Achiron A, Dolev M, Menascu S, et&#xa0;al. COVID&#x2010;19 vaccination in patients with multiple sclerosis: what we have learnt by February 2021. Mult Scler. 2021;27(6):864&#x2010;870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114441</ArticleId><ArticleId IdType="pubmed">33856242</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Wang Y, Zheng J. COVID&#x2010;19 and Alzheimer's disease: how one crisis worsens the other. Transl Neurodegener. 2021;10(1):15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8090526</ArticleId><ArticleId IdType="pubmed">33941272</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Chen C, Dong XP. Impact of COVID&#x2010;19 pandemic on patients with neurodegenerative diseases. Front Aging Neurosci. 2021;13:664965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060506</ArticleId><ArticleId IdType="pubmed">33897410</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NM, Holmes MV, Davey SG. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6041728</ArticleId><ArticleId IdType="pubmed">30002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Timpson NJ, Ebrahim S, Davey SG. Mendelian randomization: where are we now and where are we going? Int J Epidemiol. 2015;44(2):379&#x2010;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">26085674</ArticleId></ArticleIdList></Reference><Reference><Citation>The COVID&#x2010;19 host genetics initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS&#x2010;CoV&#x2010;2 virus pandemic. Eur J Hum Genet. 2020;28(6):715&#x2010;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220587</ArticleId><ArticleId IdType="pubmed">32404885</ArticleId></ArticleIdList></Reference><Reference><Citation>Degenhardt F, Ellinghaus D, Juzenas S, et&#xa0;al. Detailed stratified GWAS analysis for severe COVID&#x2010;19 in four European populations. Hum Mol Genet. 2022. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9703941</ArticleId><ArticleId IdType="pubmed">35848942</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz R, Almeida SD&#x2010;D, Heredia ML, et&#xa0;al. Novel genes and sex differences in COVID&#x2010;19 severity. Hum Mol Genet. 2022. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9652109</ArticleId><ArticleId IdType="pubmed">35708486</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, Savage JE, Watanabe K, et&#xa0;al. Genome&#x2010;wide meta&#x2010;analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51(3):404&#x2010;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Woolf B, Gill D. Plasma caffeine levels and risk of Alzheimer's disease and Parkinson's disease: mendelian randomization study. Nutrients. 2022;14(9):1697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9102212</ArticleId><ArticleId IdType="pubmed">35565667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, et&#xa0;al. Genome&#x2010;wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2010;83.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 2019;365(6460):eaav7188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241648</ArticleId><ArticleId IdType="pubmed">31604244</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol. 2015;44(2):512&#x2010;525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2010;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Wang J, Hemani G, Bowden J, Small DS. Statistical inference in two&#x2010;sample summary&#x2010;data mendelian randomization using robust adjusted profile score. Ann Stat. 2020;48(3):1742&#x2010;1769.</Citation></Reference><Reference><Citation>Verbanck M, Chen C&#x2010;Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2010;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco MFD, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926&#x2010;2940.</Citation><ArticleIdList><ArticleId IdType="pubmed">25950993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz SM, Voorhies K, Wu AC, Hokanson J, Vansteelandt S, Lange C. The influence of unmeasured confounding on the MR Steiger approach. Genet Epidemiol. 2022;46(2):139&#x2010;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8915443</ArticleId><ArticleId IdType="pubmed">35170805</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497&#x2010;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavorska OO, Burgess S. MendelianRandomization: an R package for performing mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734&#x2010;1739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5510723</ArticleId><ArticleId IdType="pubmed">28398548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, et&#xa0;al. The MR&#x2010;base platform supports systematic causal inference across the human phenome. Elife. 2018;30:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925&#x2010;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">29164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et&#xa0;al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2010;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinna P, Grewal P, Hall JP, et&#xa0;al. Neurological manifestations and COVID&#x2010;19: experiences from a tertiary care center at the frontline. J Neurol Sci. 2020;415:116969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832569</ArticleId><ArticleId IdType="pubmed">32570113</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, et&#xa0;al. Neurological and neuropsychiatric complications of COVID&#x2010;19 in 153 patients: a UK&#x2010;wide surveillance study. Lancet Psychiatry. 2020;7(10):875&#x2010;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, et&#xa0;al. Neurologic features in severe SARS&#x2010;CoV&#x2010;2 infection. N Engl J Med. 2020;382(23):2268&#x2010;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et&#xa0;al. Neurological and psychiatric risk trajectories after SARS&#x2010;CoV&#x2010;2 infection: an analysis of 2&#x2010;year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9(10):815&#x2010;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID&#x2010;19 virus targeting the CNS: tissue distribution, host&#x2010;virus interaction, and proposed neurotropic mechanisms. ACS Chem Nerosci. 2020;11(7):995&#x2010;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin&#x2010;Leclair A, et&#xa0;al. The SARS&#x2010;CoV&#x2010;2 spike protein alters barrier function in 2D static and 3D microfluidic in&#x2010;vitro models of the human blood&#x2010;brain barrier. Neurobiol Dis. 2020;146:105131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Carson MJ, El Khoury J, et&#xa0;al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015. Apr;14(4):388&#x2010;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg DF, Te Velde AA. Severe COVID&#x2010;19: NLRP3 inflammasome dysregulated. Front Immunol. 2020;11:1580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332883</ArticleId><ArticleId IdType="pubmed">32670297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejera D, Mercan D, Sanchez&#x2010;Caro JM, et&#xa0;al. Systemic inflammation impairs microglial A&#x3b2; clearance through NLRP3 inflammasome. EMBO J. 2019;38(17):e101064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717897</ArticleId><ArticleId IdType="pubmed">31359456</ArticleId></ArticleIdList></Reference><Reference><Citation>Magusali N, Graham AC, Piers TM, et&#xa0;al. A genetic link between risk for Alzheimer's disease and severe COVID&#x2010;19 outcomes via the OAS1 gene. Brain. 2021;144(12):3727&#x2010;3741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500089</ArticleId><ArticleId IdType="pubmed">34619763</ArticleId></ArticleIdList></Reference><Reference><Citation>Schooling CM, Lopez PM, Yang Z, Zhao JV, Au Yeung SL, Huang JV. Use of multivariable mendelian randomization to address biases due to competing risk before recruitment. Front Genet. 2020;11:610852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845663</ArticleId><ArticleId IdType="pubmed">33519914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Burgess S. Efficient design for mendelian randomization studies: subsample and 2&#x2010;sample instrumental variable estimators. Am J Epidemiol. 2013;178(7):1177&#x2010;1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783091</ArticleId><ArticleId IdType="pubmed">23863760</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658&#x2010;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>